Imunon, Inc.
IMNN
$1.59
$0.085.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 19.37% | 7.95% | -- | -- | -56.48% |
| Gross Profit | -19.37% | -7.95% | -- | -- | 56.48% |
| SG&A Expenses | -13.89% | -0.56% | -7.38% | -5.50% | -29.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.85% | 3.89% | 2.79% | -29.94% | -44.79% |
| Operating Income | -0.85% | -3.89% | -2.79% | 29.94% | 44.79% |
| Income Before Tax | -2.68% | -3.57% | -4.08% | 29.23% | 42.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.68% | -3.57% | -4.08% | 29.23% | 42.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.68% | -3.57% | -4.08% | 29.23% | 42.76% |
| EBIT | -0.85% | -3.89% | -2.79% | 29.94% | 44.79% |
| EBITDA | -1.06% | -3.87% | -1.89% | 30.56% | 45.54% |
| EPS Basic | 74.77% | 73.21% | 53.62% | 68.99% | 67.70% |
| Normalized Basic EPS | 74.94% | 73.21% | 53.62% | 68.99% | 67.70% |
| EPS Diluted | 74.77% | 73.21% | 53.62% | 68.99% | 67.70% |
| Normalized Diluted EPS | 74.94% | 73.21% | 53.62% | 68.99% | 67.70% |
| Average Basic Shares Outstanding | 309.69% | 286.56% | 124.41% | 128.23% | 77.22% |
| Average Diluted Shares Outstanding | 309.69% | 286.56% | 124.41% | 128.23% | 77.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |